Landon Parrow | Molecular Biophysics | Young Scientist Award

Published on by Molecular Biologist

Young Scientist Award

Landon Parrow
University of Mississippi Medical Center

Landon Parrow
Affiliation University of Mississippi Medical Center
Country United States
Documents 2
Subject Area Molecular Biophysics
Event International Molecular Biologist Awards
ORCID 0009-0005-4374-4354

Landon Parrow is an emerging American researcher whose academic activities are centered on molecular biophysics, cardiovascular physiology, aging biology, and metabolic disease research. Through training at Mississippi State University and the University of Mississippi Medical Center, he has contributed to investigations examining mechanisms of cardiac injury, lipid metabolism, fibrosis, and sex-specific physiological responses. His recent scholarly output demonstrates early-career involvement in interdisciplinary biomedical research with relevance to translational medicine and molecular health sciences.[1]

Abstract

This article summarizes the academic profile and research contributions of Landon Parrow in relation to the Young Scientist Award under the International Molecular Biologist Awards. His work focuses on molecular and physiological mechanisms associated with cardiovascular disease, metabolic dysfunction-associated steatotic liver disease, aging biology, and cellular protective pathways. Despite being at an early career stage, he has participated in peer-reviewed research addressing clinically relevant biomedical questions and has contributed to publications in recognized international journals.[2]

Keywords

Molecular Biophysics, Cardiovascular Physiology, Aging Biology, Fibrosis, Metabolic Disease, Biochemistry, Cardioprotection, Biomedical Research.

Introduction

The development of innovative biomedical research depends significantly on the contributions of early-career scientists. Landon Parrow represents a new generation of researchers engaged in exploring molecular and physiological processes underlying disease progression and therapeutic intervention. His academic pathway includes biochemistry training and research appointments associated with cardiovascular and metabolic health investigations.[1]

Research Profile

Parrow earned his academic training in Biochemistry at Mississippi State University and subsequently engaged in research activities at the University of Mississippi Medical Center. His professional progression includes appointments as Junior Researcher and Research Assistant within physiology, biophysics, and biomedical research environments. These experiences have provided opportunities to participate in multidisciplinary projects involving molecular mechanisms of disease and translational biomedical science.[1]

Research Contributions

His research contributions include investigations into cardioprotective mechanisms associated with metabolic disorders and studies examining sex-specific cardiovascular responses during accelerated aging. These projects explore biological pathways influencing lipid accumulation, cardiac fibrosis, oxidative stress regulation, and physiological adaptation. Such work contributes to the broader understanding of cardiovascular health and age-related disease mechanisms.[2][3]

Publications

  • Cardioprotective Effects of 1,3 Butanediol in MASLD via Reversal of Cardiac Lipid Accumulation and Suppression of Cardiac Fibrosis. International Journal of Molecular Sciences (2026).
  • Sex Dimorphism in the Cardiovascular Responses to d-Galactose-Induced Accelerated Aging: Effects of HO-1 Modulation. GeroScience (2026).

Research Impact

Although currently at an early stage of his scholarly career, Parrow’s publications address contemporary biomedical challenges, including cardiovascular complications associated with metabolic disease and biological aging. His participation in peer-reviewed research reflects scientific rigor and a commitment to advancing knowledge relevant to molecular medicine and physiological health.[2][3]

Award Suitability

The Young Scientist Award recognizes promising researchers who demonstrate academic excellence, research productivity, and future leadership potential. Based on his educational achievements, research appointments, and peer-reviewed publications in internationally recognized journals, Landon Parrow demonstrates characteristics aligned with the objectives of this recognition. His work contributes to emerging knowledge in molecular biophysics and biomedical science while supporting ongoing advancements in translational research.[4]

Conclusion

Landon Parrow has established an encouraging foundation for a research career focused on molecular and physiological mechanisms of disease. Through contributions to studies involving cardiovascular pathology, metabolic dysfunction, and aging biology, he has demonstrated scientific engagement and potential for future impact. His profile represents the qualities typically associated with promising early-career investigators in the biomedical sciences.

References

  1. ORCID. (2026). Landon Parrow: Employment history, education, and professional profile.
    https://orcid.org/0009-0005-4374-4354
  2. Parrow, L., et al. (2026). Cardioprotective Effects of 1,3 Butanediol in MASLD via Reversal of Cardiac Lipid Accumulation and Suppression of Cardiac Fibrosis. International Journal of Molecular Sciences.
    DOI:https://doi.org/10.3390/ijms27125354
  3. Parrow, L., et al. (2026). Sex Dimorphism in the Cardiovascular Responses to d-Galactose-Induced Accelerated Aging: Effects of HO-1 Modulation. GeroScience.
    DOI:https://doi.org/10.1007/S11357-026-02165-3
  4. International Molecular Biologist Awards. (2026). Young Scientist Award criteria and recognition framework.
    molecularbiologist.org
  5. Elsevier. (n.d.). Scopus author details: Landon Parrow
  6. University of Mississippi Medical Center. (2026). Research and academic activities in Physiology and Biophysics.

Weiwei Fu | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. Weiwei Fu | Molecular Biology | Best Researcher Award 

Research assistant professor, at Peking University Third Hospital, China.

Dr. Fu Weiwei is an accomplished medical scientist specializing in gastroenterology and immunology. She currently serves as an Assistant Research Professor and Laboratory Director at the Gastroenterology Department, Peking University Third Hospital, where she leads research at the Beijing Key Laboratory. Dr. Fu earned her Ph.D. in Immunology from Peking University Health Science Center and has a strong foundation in traditional medicine, holding a Bachelor of Medicine from Shandong University. With more than a decade of experience in translational medical research, her work bridges cutting-edge immunological discoveries and practical clinical applications. Her focus lies in immune microenvironment dynamics, gastrointestinal tumor evolution, and the integration of traditional Chinese medicine for digestive disease therapies. She has delivered several high-profile international presentations and has published widely in leading scientific journals. Her contributions have significantly advanced the field of digestive immunology.

Professional Profile

Scopus

ORCID

🎓 Education

Dr. Fu’s academic journey began with a 5-year Bachelor of Medicine program at Shandong University of Traditional Chinese Medicine (2002–2007), where she laid a solid foundation in both conventional and traditional healthcare practices. Her early exposure to integrative medicine inspired a unique perspective on digestive health and immune response. Motivated by scientific rigor, she enrolled in the Combined Master’s and Ph.D. Program in Immunology (2008–2013) at Peking University Health Science Center, mentored by Prof. Wenling Han. This elite program sharpened her skills in molecular biology, immunopathology, and clinical translational research. Throughout her doctoral years, she focused on the host immune responses in cancer, particularly those related to gastric inflammation and tumorigenesis. This diverse academic training enables her to merge modern biomedical technologies with traditional insights, giving her an edge in the multidisciplinary field of digestive immunology.

🧪 Experience

Dr. Fu brings a wealth of research and clinical experience to her current position at the Gastroenterology Department, Peking University Third Hospital (2019–present), where she directs the Beijing Key Laboratory. As an Assistant Research Professor, she leads a team focusing on translational immunology in gastrointestinal diseases. Before this, she completed a prestigious postdoctoral fellowship (2013–2019) at the Tsinghua University Institute of Immunology under Prof. Chen Dong, an Academician of the Chinese Academy of Sciences. During this time, she worked on T-cell signaling, immune checkpoints, and the role of lymphoid cells in cancer. Her lab currently integrates clinical cohort data with multi-omics techniques to explore disease mechanisms. She is also instrumental in mentoring junior researchers and clinicians. Her work bridges laboratory immunology with bedside applications, ensuring scientific advancements are translated into improved diagnosis and therapy for patients.

🔬 Research Interests

Dr. Fu’s research centers on the immune microenvironment in gastrointestinal tumors and digestive tract diseases, such as gastric cancer and inflammatory bowel disease. She applies multi-omics technologies—including single-cell RNA sequencing, proteomics, and microbiome analysis—to decipher host-pathogen interactions and immune cell dynamics during disease evolution. A key aspect of her research is understanding how Helicobacter pylori infection initiates gastric lesions, tumor progression, and immune escape. She also investigates traditional Chinese medicine-based therapies, exploring their role in cancer prevention and immune modulation. Another focal point is early screening and biomarker discovery for precancerous lesions through clinical cohort studies. By integrating high-throughput data with clinical insights, her work aims to improve patient stratification and individualized treatments. Her interdisciplinary approach bridges immunology, oncology, and traditional medicine, placing her at the forefront of gastrointestinal research in China and beyond.

🏆 Awards

Dr. Fu’s scientific excellence has been consistently recognized. She won the Outstanding Paper Award at the 2023 Chinese Medical Association’s National Conference on Digestive Diseases (CGC 2023) for her oral presentation on immune profiling during colorectal cancer progression. Her continuous contributions to clinical immunology, translational oncology, and molecular diagnostics have earned her accolades from both national and international platforms. Her selection as an oral presenter at leading conferences—such as DDW 2024 in Washington, D.C., and UEGW 2023 in Copenhagen—speaks to her international recognition. She has also received patent grants for innovations in inflammation and cancer therapy, reflecting her drive for practical applications. As a dedicated researcher, educator, and innovator, Dr. Fu stands out as a top candidate for award nominations in the fields of biomedical research and clinical translational science.

📚 Top Noted Publications

Dr. Fu has authored and co-authored numerous impactful papers in top-tier journals (JCR Q1–Q3), often as first or corresponding author. Below are select publications with hyperlink.

2025

  1. Luteolin Improves Precancerous Gastric Mucosa by Binding STAT3
    International Journal of Biological Sciences (Q1, IF 8.1)
    📌 Co-Corresponding Author
    🧪 Original Research

  2. CMTM3 Regulates Colitis-Associated Cancer Progression
    Cellular and Molecular Gastroenterology and Hepatology (CMGH) (Q1, IF 7.1)
    📌 Co-Corresponding Author
    🧬 Original Research

  3. Cmtm4 Deficiency Exacerbates H. pylori-Induced Gastric Carcinogenesis
    Pathology International (Q2, IF 2.5)
    📌 Co-Corresponding Author
    🦠 Original Research

  4. The Host Immune Response Landscape in Gastric Cancer Development
    Clinical and Experimental Immunology (Q2, IF 3.4)
    📌 First Author
    🧫 Original Research

2024

  1. Neutrophil Heterogeneity in Hepatocellular Carcinoma and Tumor Immunity
    Cancer Medicine (Q2, IF 2.9)
    📌 Co-First Author
    🔬 Original Research

  2. Oxidative Balance in Diet and Sleep Patterns: A Metabolic Interaction
    Frontiers in Nutrition (Q2, IF 4.0)
    📌 Co-First Author
    🍽 Original Research

  3. CMTM4 Facilitates Gastric Cancer Metastasis via EMT Modulation
    Journal of Gastrointestinal Oncology (Q3, IF 2.0)
    📌 Co-First Author
    🧠 Original Research

  4. Cmtm4 Shapes Colitis Outcomes via Microbial Dysbiosis and Mucosal Immunity
    Journal of Genetics and Genomics (Q1, IF 6.6)
    📌 Co-Corresponding Author
    🧪 Original Research

  5. Serum Proteomics-Based Biomarkers of Precancerous Gastric Lesions
    Frontiers in Molecular Biosciences (Q2, IF 3.9)
    📌 Co-Corresponding Author
    🔍 Original Research

  6. Treg Subsets Orchestrate Tumor Microenvironment in Colorectal Cancer
    Frontiers in Immunology (Q1, IF 5.7)
    📌 Co-First & Corresponding Author
    🧫 Original Research

2023

  1. Helicobacter pylori and Inflammasome Activation in Gastric Pathogenesis (Review)
    Helicobacter (Q2, IF 4.3)
    📌 Co-Corresponding Author
    🧯 Review Article

2022

  • Lymphocyte Profile Alterations in Precancerous Gastric Lesions
    Journal of Leukocyte Biology (Q2, IF 5.5)
    📌 First Author
    🧬 Original Research

  • B7 Family Molecules and Immune Evasion in H. pylori Infection (Review)
    Helicobacter (Q2, IF 4.4)
    📌 Co-Corresponding Author
    🧫 Review Article

Conclusion

Dr. FU Weiwei demonstrates an exceptional and well-rounded profile as a medical researcher with significant contributions to immunology and gastroenterology, supported by prestigious academic training, a robust scientific publication record, impactful patents, and strong conference presence. These achievements, particularly in translational cancer immunology, make Dr. Fu highly suitable for the Best Researcher Award.